Press Release Exubrion Therapeutics® Appoints Jennifer Kirk to Board of Directors; Names Her CEO 18 March 2025
Press Release Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment 18 March 2025
Press Release Spring Health Launches Neurodiversity Hub to Support Employees, Families, and Leaders 18 March 2025
Press Release Digital Travel Credentials Take Off, Achieving 15% Global Penetration by 2032 18 March 2025
Press Release Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren’s disease, has now received Fast Track designation 18 March 2025
Press Release Supply & Demand Chain Executive Honors LogicSource Leader, Erik Given, in the 2025 Pros to Know Awards 18 March 2025
